Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2004-000087-27 | EudraCT Number |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This trial is conducted in Europe and the United States of America (USA). The purpose of this study is to test whether insulin detemir is a safe and at least as effective alternative to insulin glargine for the control of blood glucose in basal/bolus therapy in patients with type 2 diabetes.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| insulin detemir | Drug | |||
| insulin glargine | Drug | |||
| insulin aspart | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| HbA1c | after 1 year trial period |
| Measure | Description | Time Frame |
|---|---|---|
| Adverse events | ||
| Body weight | ||
| Hypoglycemia |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Global Clinical Registry (GCR, 1452) | Novo Nordisk A/S | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Novo Nordisk Investigational Site | Little Rock | Arkansas | 72204 | United States | ||
| Novo Nordisk Investigational Site |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 19108786 | Result | Hollander P, Cooper J, Bregnhoj J, Pedersen CB. A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes. Clin Ther. 2008 Nov;30(11):1976-87. doi: 10.1016/j.clinthera.2008.11.001. |
| Label | URL |
|---|---|
| Clinical Trials at Novo Nordisk | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Blood glucose |
| Insulin Treatment Satisfaction |
| Inglewood |
| California |
| 90301 |
| United States |
| Novo Nordisk Investigational Site | San Francisco | California | 94143-0780 | United States |
| Novo Nordisk Investigational Site | Santa Ana | California | 92705 | United States |
| Novo Nordisk Investigational Site | Spring Valley | California | 91978 | United States |
| Novo Nordisk Investigational Site | Boca Raton | Florida | 33433 | United States |
| Novo Nordisk Investigational Site | Jacksonville | Florida | 32216 | United States |
| Novo Nordisk Investigational Site | Lake Mary | Florida | 32746 | United States |
| Novo Nordisk Investigational Site | Melbourne | Florida | 32901 | United States |
| Novo Nordisk Investigational Site | Orlando | Florida | 32804 | United States |
| Novo Nordisk Investigational Site | Palm Harbor | Florida | 34684 | United States |
| Novo Nordisk Investigational Site | Vero Beach | Florida | 32960 | United States |
| Novo Nordisk Investigational Site | Athens | Georgia | 30606 | United States |
| Novo Nordisk Investigational Site | Idaho Falls | Idaho | 83404-7596 | United States |
| Novo Nordisk Investigational Site | Topeka | Kansas | 66606 | United States |
| Novo Nordisk Investigational Site | Omaha | Nebraska | 68114 | United States |
| Novo Nordisk Investigational Site | Las Vegas | Nevada | 89119-6100 | United States |
| Novo Nordisk Investigational Site | Berlin | New Jersey | 08009 | United States |
| Novo Nordisk Investigational Site | Asheville | North Carolina | 28803 | United States |
| Novo Nordisk Investigational Site | Hermitage | Pennsylvania | 16148 | United States |
| Novo Nordisk Investigational Site | Philadelphia | Pennsylvania | 19107 | United States |
| Novo Nordisk Investigational Site | Dallas | Texas | 75235 | United States |
| Novo Nordisk Investigational Site | Dallas | Texas | 75246 | United States |
| Novo Nordisk Investigational Site | Dallas | Texas | 75390-8858 | United States |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78229 | United States |
| Novo Nordisk Investigational Site | Newport News | Virginia | 23606 | United States |
| Novo Nordisk Investigational Site | Richmond | Virginia | 23249 | United States |
| Novo Nordisk Investigational Site | Tacoma | Washington | 98405 | United States |
| Novo Nordisk Investigational Site | Espoo | 02740 | Finland |
| Novo Nordisk Investigational Site | Helsinki | 00260 | Finland |
| Novo Nordisk Investigational Site | Kurikka | FI-61300 | Finland |
| Novo Nordisk Investigational Site | Lahti | FI-15110 | Finland |
| Novo Nordisk Investigational Site | Lapua | FI-62100 | Finland |
| Novo Nordisk Investigational Site | Oulu | FI-90220 | Finland |
| Novo Nordisk Investigational Site | Turku | 20700 | Finland |
| Novo Nordisk Investigational Site | Brest | 29200 | France |
| Novo Nordisk Investigational Site | Le Mans | France |
| Novo Nordisk Investigational Site | Montpellier | 34295 | France |
| Novo Nordisk Investigational Site | Nanterre | 92014 | France |
| Novo Nordisk Investigational Site | Narbonne | 11108 | France |
| Novo Nordisk Investigational Site | Nevers | 58033 | France |
| Novo Nordisk Investigational Site | Orléans | France |
| Novo Nordisk Investigational Site | Paris | 75181 | France |
| Novo Nordisk Investigational Site | Vénissieux | 69200 | France |
| Novo Nordisk Investigational Site | Bergen | NO-5009 | Norway |
| Novo Nordisk Investigational Site | Notodden | NO-3675 | Norway |
| Novo Nordisk Investigational Site | Sarpsborg | 1723 | Norway |
| Novo Nordisk Investigational Site | Ski | NO-1400 | Norway |
| Novo Nordisk Investigational Site | Stavanger | 4011 | Norway |
| Novo Nordisk Investigational Site | Trondheim | NO-7030 | Norway |
| Novo Nordisk Investigational Site | Ängelholm | 262 91 | Sweden |
| Novo Nordisk Investigational Site | Falun | 791 82 | Sweden |
| Novo Nordisk Investigational Site | Gothenburg | 417 17 | Sweden |
| Novo Nordisk Investigational Site | Kalmar | 391 85 | Sweden |
| Novo Nordisk Investigational Site | Lund | 221 85 | Sweden |
| Novo Nordisk Investigational Site | Lund | 223 70 | Sweden |
| Novo Nordisk Investigational Site | Malmö | 214 26 | Sweden |
| Novo Nordisk Investigational Site | Motala | 591 85 | Sweden |
| Novo Nordisk Investigational Site | Oskarshamn | 572 28 | Sweden |
| Novo Nordisk Investigational Site | Uddevalla | 451 50 | Sweden |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D003924 | Diabetes Mellitus, Type 2 |
| ID | Term |
|---|---|
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000069057 | Insulin Detemir |
| D000069036 | Insulin Glargine |
| D061267 | Insulin Aspart |
| ID | Term |
|---|---|
| D049528 | Insulin, Long-Acting |
| D061385 | Insulins |
| D010187 | Pancreatic Hormones |
| D036361 | Peptide Hormones |
| D006728 | Hormones |
| D006730 | Hormones, Hormone Substitutes, and Hormone Antagonists |
| D010455 | Peptides |
| D000602 | Amino Acids, Peptides, and Proteins |
| D061266 | Insulin, Short-Acting |
Not provided
Not provided